Dietary Polyphenols Targeting Arterial Stiffness: Interplay of Contributing Mechanisms and Gut Microbiome-Related Metabolism

Abstract

Increased arterial stiffness is a degenerative vascular process, progressing with age that leads to a reduced capability of arteries to expand and contract in response to pressure changes. This progressive degeneration mainly affects the extracellular matrix of elastic arteries and causes loss of vascular elasticity. Recent studies point to significant interference of dietary polyphenols with mechanisms involved in the pathophysiology and progression of arterial stiffness. This review summarizes data from epidemiological and interventional studies on the effect of polyphenols on vascular stiffness as an illustration of current research and addresses possible etiological factors targeted by polyphenols, including pathways of vascular functionality, oxidative status, inflammation, glycation, and autophagy. Effects can either be inflicted directly by the dietary polyphenols or indirectly by metabolites originated from the host or microbial metabolic processes. The composition of the gut microbiome, therefore, determines the resulting metabolome and, as a consequence, the observed activity. On the other hand, polyphenols also influence the intestinal microbial composition, and therefore the metabolites available for interaction with relevant targets. As such, targeting the gut microbiome is another potential treatment option for arterial stiffness.

Polyphenols in Alzheimer’s Disease and in the Gut–Brain Axis

“…Curcumin-PEG-PLA nanoparticles, for example, cross the BBB six- Chlorogenic acid-derived catabolites, such as dihydrocaffeic acid, dihydroferulic acid and feruloylglycine, were also shown to be effective neuroprotectors [45]. Polyphenols also affect the gut microbiota composition, thereby modulating the composition of the metabolites [62]. Thus, the effect of polyphenolic compounds on neurodegeneration is mediated by multiple mechanisms, among which the antiglycating and antioxidant activity of the polyphenols may play a significant role in neuroprotection in AD and other neurodegenerative diseases.…”

A Mixture of Phenolic Metabolites of Quercetin Can Decrease Elevated Blood Pressure of Spontaneously Hypertensive Rats Even in Low Doses

“…It is well known that some flavonoids administered orally can decrease arterial blood pressure [1,2]. The bioavailability of parent flavonoids is however low [3] and hence the observed effect could be mediated by their metabolites [4,5]. Although there are some data on conjugates of flavonoids [6], colonic metabolites seem to be more active vasodilators, as was shown recently ex vivo as well as in vivo in spontaneously hypertensive rats (SHR) [7,8].…”

New Insights for Cellular and Molecular Mechanisms of Aging and Aging-Related Diseases: Herbal Medicine as Potential Therapeutic Approach

“…Flavonoids are a kind of natural polyphenols, mainly including flavonoids, flavanols, flavonoids, anthocyanins, and isoflavones [225]. Studies had shown that flavonoids had definite efficacy in the treatment of agerelated neurodegenerative diseases [226], cardiovascular diseases [227,228], atherosclerosis [229], etc. Some progress has Modulation of the mitochondrial pathway of apoptosis and the cholinergic system [186] 12…”